The entire basis of Oncolix last few years of Studies just pulled what we call a "J Donald"
Oncolix Fooled Investors by promoting clinical trials of PRolanta, (a product that no one can ever prove is manufactured?) and touted lies of positive studies with the help of funder GHS.?
Lisa Johnson explained to shareholder about efficiancies and progress of a clinical trial that has just ended in disaster?
Study Start Date : February 2016
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : January 2018
Prolanta trials have ended according to the United States Governing body of Clinical trials (I know Michael T Redman says differently)
But where is his link to provide the trials have extended past the actual clinical trial dates?
What does a company do when there entire basis of pump and dump and bleeding on the hearts of cancer victims do when they have reached the end of the line?
They quickly switch studies and ignore an entire 2 years?
Ovarian Cancer out ?
Now Uterine Cancer in?
Oncolix will not provide any information that they dosed 1 single (female) patient over the last 2 years of studies but now that the trials have ended?
They are Abandoning the very fabric of the company and pulling the plug on these very women they promised a chance of life with?
You cant make claims of a 2 year study?
Produce no info
Produce no studies
Produce no results
Produce no manufacturer
Produce no participants
Redman sold millions of shares for cash over the last 2 years and diluted the PPS into the ground of the very trials it sat in for 2 years?
And Now shareholders just have to pretend the trials never happened and the company just up and shifted focus?
Lets see what the next 2 years of failure does for a PPS that has already lost 75% of its value?